Real-world chemotherapy use and survival outcomes in postmenopausal HR+/HER2−breast cancer with low genomic risk (RS ≤ 25): a multicenter cohort study from China

C Chengye Hong D Duanduan Wang Y Yongwu Chen S Songping Lin Y Yidong Huang L Liangqiang Li D Debo Chen W Weibin Lian

Article Details

Volume / Issue Vol. 16, Issue 1
Published May 02, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (8)

C

Chengye Hong

D

Duanduan Wang

Y

Yongwu Chen

S

Songping Lin

Y

Yidong Huang

L

Liangqiang Li

D

Debo Chen

W

Weibin Lian